Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of intravenous haloperidol for chronic migraine with or without medication overuse
2009-011009-18Phase 2Terminated
- Sponsor
- Azienda Ospedaliero Universitaria di Cagliari
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of haloperidol in chronic migraine and medication overuse headache (MOH), sponsored by Azienda Ospedaliero Universitaria di Cagliari. Primary endpoints: Reduction in headache days per month, Reduction in symptomatic medication use days per month and 2 more. Started Jun 2009; status: terminated.
02
Drugs
haloperidol
03
Conditions
chronic migrainemedication overuse headache (MOH)
Beyond the preview
Go deeper on 2009-011009-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011009-18.